NIH-funded research NIH-funded research

TopoROP: Multi-View Analysis to Diagnose Retinopathy of Prematurity

Official title: TopoROP: Multi-View Topology-Integrated Analytics for Diagnosis of Retinopathy of Prematurity

Funded at Queens College · NIH-11424612 · Data updated 2026-11-12

A new AI-based tool analyzes retinal images to help doctors diagnose Retinopathy of Prematurity in premature babies and other patients at risk.

More Prematurity research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionQueens College
NIH-funded
Lab location1 site (Flushing, United States)
Project startSeptember 15, 2026
Project endAugust 31, 2030
Funding year2026
Award (this year)$604,000
NIH project number1R16EY039206-01
Project IDNIH-11424612 on NIH RePORTER

Who could benefit from this research

Could help

Premature infants at risk for Retinopathy of Prematurity and adults with age-related retinal vascular concerns may benefit from the platform’s diagnostic insights.

Less likely to help

If a patient’s condition is unrelated to retinal vascular disease or if data quality is insufficient, they may not benefit from this tool.

What this research studies

This grant supports developing an AI platform that looks at the retinal blood vessel network in multiple views to improve early and accurate detection of Retinopathy of Prematurity. The approach aims to go beyond single-image checks by capturing network-level features that reflect disease progression. Researchers will build and test models on retinal data from affected patients and compare performance to current diagnostic methods. If successful, the tool could assist clinicians in making timely treatment decisions to prevent vision loss in vulnerable populations.

Why it matters

Potential benefit: Clinicians could diagnose ROP more accurately and earlier, potentially reducing childhood blindness and its social and economic impact.

How similar studies have gone: Prior AI approaches often face limitations with local vessel features; this project emphasizes network-level biomarkers, representing an innovative but increasingly explored avenue with promising early signals.

Where this research is happening

  • Queens College
    Flushing, United States
    Active

Researchers

  • Principal investigator: Tsai, Chia-Ling — Queens College
  • Study coordinator: Tsai, Chia-Ling

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.